Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Thermo Fisher Scientific expands France hub to get drugs from development to commercial manufacturing quicker

By Heather Hall | April 7, 2023

Thermo Fisher Scientific is adding early development work for oral solid dose therapies to its Bourgoin, France site, enabling that location to address customers’ workflow from early drug development through commercial manufacturing and underscoring the company’s commitment to helping clients get medicines to patients sooner.

Thermo Fisher Scientific celebrated the opening of its early development hub in Bourgoin, France, enabling the site to support customers in oral solid dose formulations from early drug development through commercial manufacturing. Pictured from left to right: Anil Kane, senior director of global technical and scientific affairs, pharma services; Hrissi Samartzidou, vice president of marketing, pharma services; Isabelle Lafosse-Marin, senior director and general manager, Bourgoin site; Leon Wyszkowski, president of commercial operations, pharma services; Denis Giraud, Mayor of Ruy; Jean-Pierre Girard, Regional Councilor and first assistant of Mayor of Bourgoin-Jallieu; Jean Papadopulo, President of Intermunicipal organization of Isère (CAPI); Christophe Carron, President of Chamber of Commerce and Industry (CCI); and Clément Herboux-Dubois, Parliamentary Collaborator of the Deputy.

“In the last decade, Thermo Fisher has led and advanced the field of oral solid dose development, with 126 new drug approvals supported,” said Leon Wyszkowski, president of pharma services commercial operations. “Expanding our capabilities in France is a further investment in our global oral solid network that will allow us to further forge partnerships with customers who depend on our capabilities for the development and commercial production of lifesaving drugs for their patients.”

In late 2021, the French government’s France Relance economic stimulus plan provided a grant to support the early development hub. Construction work began during the first quarter of 2022 enabling the first activities to be launched in June 2022.

In addition to expanded good manufacturing practices (GMP) facilities, the early development hub includes a 430-m2 (4,600 ft2) research and development facility for preclinical, non-GMP operations.

Bourgoin is a Thermo Fisher center of excellence in Europe for oral solid dose end-to-end drug product development and highly potent substance handling. Capabilities there encompass all conventional oral solid dose manufacturing equipment to deliver tablets, capsules, and granules, as well as specialized technologies such as compaction and compression-contained simulation and Accelerated Stability Assessment Program (ASAP) simulation.

This expansion in Bourgoin builds on the company’s investments in small molecule solutions, including oral solid dose development and manufacturing services in Bend, Oregon; Greenville, N.C.; Cincinnati; Manatí, Puerto Rico; Toronto; Whitby, Canada; and Milton Park, U.K.

 

 

 

 

Related Articles Read More >

Replacing animal models? Silk sponge 3D cell culture system shows high potential for cancer diagnostics and drug screening
Japanese drug shows promise in preventing COVID-19 infection
8 major R&D moves this week: Roche/Genentech moves to Harvard, TSMC invests $100B, ThyssenKrupp cuts jobs and more
7 major R&D moves this week: Apple expands U.S. manufacturing, Lilly plans new plants, tech giants advance in computing
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE